Lambrecht, Stijn <br/><br/>
Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis development.  [electronic resource] 

 -  Arthritis & rheumatology (Hoboken, N.J.)  Feb 2014 
 - 418-27 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2326-5205 
<br/><br/><label>Standard No.: </label>10.1002/art.38241  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Biomarkers--metabolism<br/>Bleomycin--adverse effects<br/>Chemokine CCL2--metabolism<br/>Cohort Studies<br/>Comorbidity<br/>Disease Models, Animal<br/>Fibroblasts--drug effects<br/>Follow-Up Studies<br/>Growth Differentiation Factor 15--deficiency<br/>Humans<br/>In Vitro Techniques<br/>Interleukin-6--metabolism<br/>Longitudinal Studies<br/>Lung--drug effects<br/>Mice<br/>Mice, Knockout<br/>Prospective Studies<br/>Pulmonary Fibrosis--epidemiology<br/>Scleroderma, Systemic--chemically induced<br/>Skin Diseases--epidemiology<br/>Stromal Cells--metabolism